MACK Annual Working Capital
$18.74 M
-$496.00 K-2.58%
31 December 2023
Summary:
As of February 5, 2025, MACK annual working capital is $18.74 million, with the most recent change of -$496.00 thousand (-2.58%) on December 31, 2023. During the last 3 years, it has risen by +$2.97 million (+18.82%).MACK Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MACK Quarterly Working Capital
$221.65 M
+$202.90 M+1082.56%
01 March 2024
Summary:
As of February 5, 2025, MACK quarterly working capital is $221.65 million, with the most recent change of +$202.90 million (+1082.56%) on March 1, 2024. Over the past year, it has increased by +$202.85 million (+1078.91%).MACK Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MACK Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.6% | +1078.9% |
| 3 y3 years | +18.8% | +1078.9% |
| 5 y5 years | -69.4% | +1078.9% |
MACK Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -82.8% | at high |
Merrimack Pharmaceuticals Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $221.65 M(+1082.6%) |
| Dec 2023 | $18.74 M(-2.6%) | $18.74 M(-0.3%) |
| Sept 2023 | - | $18.80 M(-1.2%) |
| June 2023 | - | $19.03 M(-0.7%) |
| Mar 2023 | - | $19.16 M(-0.4%) |
| Dec 2022 | $19.24 M(+36.2%) | $19.24 M(+46.0%) |
| Sept 2022 | - | $13.18 M(-3.1%) |
| June 2022 | - | $13.60 M(-3.2%) |
| Mar 2022 | - | $14.05 M(-0.5%) |
| Dec 2021 | $14.12 M(-10.5%) | $14.12 M(-2.7%) |
| Sept 2021 | - | $14.51 M(-2.9%) |
| June 2021 | - | $14.94 M(-4.0%) |
| Mar 2021 | - | $15.57 M(-1.3%) |
| Dec 2020 | $15.77 M(-0.9%) | $15.77 M(-4.2%) |
| Sept 2020 | - | $16.47 M(-3.3%) |
| June 2020 | - | $17.03 M(+2.1%) |
| Mar 2020 | - | $16.68 M(+4.7%) |
| Dec 2019 | $15.92 M(-74.0%) | $15.92 M(-9.8%) |
| Sept 2019 | - | $17.66 M(-53.1%) |
| June 2019 | - | $37.62 M(-27.5%) |
| Mar 2019 | - | $51.88 M(-15.4%) |
| Dec 2018 | $61.31 M(-18.5%) | $61.31 M(-6.0%) |
| Sept 2018 | - | $65.20 M(+48.7%) |
| June 2018 | - | $43.84 M(-26.4%) |
| Mar 2018 | - | $59.58 M(-20.8%) |
| Dec 2017 | $75.27 M | $75.27 M(-7.1%) |
| Sept 2017 | - | $81.02 M(-3.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2017 | - | $83.83 M(-235.8%) |
| Mar 2017 | - | -$61.73 M(+100.5%) |
| Dec 2016 | -$30.79 M(-131.5%) | -$30.79 M(-2407.9%) |
| Sept 2016 | - | $1.33 M(-95.3%) |
| June 2016 | - | $28.14 M(-55.5%) |
| Mar 2016 | - | $63.32 M(-35.2%) |
| Dec 2015 | $97.65 M(+366.0%) | $97.65 M(-501.2%) |
| Sept 2015 | - | -$24.34 M(-27.8%) |
| June 2015 | - | -$33.73 M(+664.6%) |
| Mar 2015 | - | -$4.41 M(-121.1%) |
| Dec 2014 | $20.95 M(-80.8%) | $20.95 M(-48.8%) |
| Sept 2014 | - | $40.91 M(+214.8%) |
| June 2014 | - | $12.99 M(-84.1%) |
| Mar 2014 | - | $81.89 M(-24.8%) |
| Dec 2013 | $108.91 M(+21.3%) | $108.91 M(-21.9%) |
| Sept 2013 | - | $139.42 M(+394.4%) |
| June 2013 | - | $28.20 M(-51.7%) |
| Mar 2013 | - | $58.44 M(-34.9%) |
| Dec 2012 | $89.78 M(+127.7%) | $89.78 M(+18.3%) |
| Sept 2012 | - | $75.89 M(-19.0%) |
| June 2012 | - | $93.65 M(+346.2%) |
| Mar 2012 | - | $20.99 M(-46.8%) |
| Dec 2011 | $39.44 M(+97.6%) | $39.44 M(-14.4%) |
| Sept 2011 | - | $46.07 M(-28.2%) |
| June 2011 | - | $64.20 M(+314.8%) |
| Mar 2011 | - | $15.48 M(-22.5%) |
| Dec 2010 | $19.96 M(-188.4%) | $19.96 M |
| Dec 2009 | -$22.58 M | - |
FAQ
- What is Merrimack Pharmaceuticals annual working capital?
- What is the all time high annual working capital for Merrimack Pharmaceuticals?
- What is Merrimack Pharmaceuticals annual working capital year-on-year change?
- What is Merrimack Pharmaceuticals quarterly working capital?
- What is the all time high quarterly working capital for Merrimack Pharmaceuticals?
- What is Merrimack Pharmaceuticals quarterly working capital year-on-year change?
What is Merrimack Pharmaceuticals annual working capital?
The current annual working capital of MACK is $18.74 M
What is the all time high annual working capital for Merrimack Pharmaceuticals?
Merrimack Pharmaceuticals all-time high annual working capital is $108.91 M
What is Merrimack Pharmaceuticals annual working capital year-on-year change?
Over the past year, MACK annual working capital has changed by -$496.00 K (-2.58%)
What is Merrimack Pharmaceuticals quarterly working capital?
The current quarterly working capital of MACK is $221.65 M
What is the all time high quarterly working capital for Merrimack Pharmaceuticals?
Merrimack Pharmaceuticals all-time high quarterly working capital is $221.65 M
What is Merrimack Pharmaceuticals quarterly working capital year-on-year change?
Over the past year, MACK quarterly working capital has changed by +$202.85 M (+1078.91%)